In humans, genetic variants in the APOA1 –APOC3–APOA4 cluster has been associated with the risk of Alzheimer disease, polycythemia induced gastric injury, and metabolic syndrome42–44. Here, APOA1 is linked to early-onset autosomal dominant Alzheimer disease.